UK Responsible Person vs EU Authorised Representative: Key Differences For Non‑UK Manufacturers

UK Responsible Person for Medical Devices A UK-based representative appointed by a non-UK manufacturer to carry out specified medical-device responsibilities in Great Britain. This role is specific to Great Britain and must be filled by an entity established in GB; it mirrors aspects of the EU Authorised Representative but operates under UK law and on a different territorial basis.

Manufacturers who sell into multiple markets often confuse the UK RP with the EU Authorised Representative (EU AR). Both roles provide local regulatory contact points and help with documentation and post‑market activities, but the legal frameworks, territorial scope, and technical details differ. Understanding these differences reduces compliance gaps and prevents parallel failures that can interrupt supply to retailers and patients.

Territorial Scope And Legal Basis

The primary distinction is geography and legal regime. The UK RP covers Great Britain only (England, Scotland, Wales). The EU AR covers the EU and, where applicable, the EEA. The legal foundations are different: the UK RP role is defined under UK regulations and MHRA guidance, while the EU AR is defined under the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) or previous directives.

Who Can Be Appointed

The legal requirement for establishment differs. A UK RP must be established in Great Britain; the EU AR must be established in the EU/EEA. A single organisation cannot legally serve both roles unless it has a legal presence in each jurisdiction. Many global service providers offer parallel teams or sister companies to act in each territory.

Regulatory Responsibilities: Similarities And Differences

Both roles handle similar functional tasks: being the point of contact for authorities, holding or being able to access technical documentation, and supporting incident reporting. Differences emerge in procedural detail and expected deliverables:

• Technical File Access: UK RP must have access to the technical file or retain it; EU AR often needs to sign a mandate and be able to provide documentation under EU rules.
• Conformity Marks: EU AR supports CE-marked devices; UK RP supports UKCA marking and GB regulatory submission needs.
• Notifications And Registers: The EU AR may be referenced in EUDAMED-related processes (as applicable), while the UK RP interacts with MHRA systems and processes unique to the GB market.

Contractual Considerations And Liability

Contracts with each type of representative must be explicit. Manufacturers must define who handles which obligations, who has access to documents, and how incident response is coordinated. Liability differs because the legal duties arise under separate regulatory frameworks — a breach in the UK does not automatically create EU liability, but reputational or commercial fallout can be global.

Operational Implications For Supply Chain Partners

Retailers and distributors should verify whether the devices they source from non‑GB manufacturers are supported by a UK RP for GB sales and by an EU AR for EU sales. Practical checks include confirmation letters, the registered address of the representative, and a copy of the mandate. For cross-border sellers, having both representatives avoids market access interruption and eases incident management in each jurisdiction.

Example Scenarios

Scenario 1 — A US manufacturer sells class III devices in the EU and GB. They appoint an EU AR in Dublin and a separate UK RP in London. Both representatives sign mandates and coordinate on the technical file. Scenario 2 — A Japanese SME with limited resources appoints one global regulatory service provider that operates through a UK company for GB duties and through an EU subsidiary for EU duties; separate contracts and local points of contact are maintained to satisfy both legal regimes.

Practical Checklist For Choosing Representatives

• Jurisdictional Coverage: Confirm which territories each appointment covers and whether you need separate representatives.
• Mandate Clarity: Use written mandates that explicitly list duties and access to technical documentation.
• Local Competence: Choose representatives familiar with local regulatory processes (MHRA for GB, MDR/IVDR for EU).
• Coordination Protocols: Establish escalation and information‑sharing protocols to manage incidents across markets.

In short, the UK Responsible Person for Medical Devices and the EU Authorised Representative perform analogous roles in different jurisdictions; non‑UK manufacturers must appoint the correct representative(s) with explicit mandates and operational plans to ensure continuous compliant market access.